A. CEO ASSESSMENT AND OUTLOOK … and over 3-year target period Operating profit (EUR bn) RoE(%) 13.4bn 13.2% 10.6% 11.5bn 20bn 20bn Target Target Performance CAGR 14.9%1 -3%-p +5% 2018 2021 2018 2021 2 3 NPS (%) IMIX (%) 20bn 71% 78% 74% 84% Target Target Health +10%-p +7%-p 2018 2021 2018 2021 1) RoEadjusted for the provision for the AllianzGI U.S. Structured Alpha matter 2) Percentage reflects share of businesses with NPS (Net Promoter Score) above market average or loyalty leader 6 3) IMIX = Inclusive Meritocracy Index A 4
Analyst Presentation Page 5 Page 7